Ophthalmic Viscosurgical Devices - Global Strategic Business Report

The global market for Ophthalmic Viscosurgical Devices was estimated at US$429.8 Million in 2024 and is projected to reach US$564.3 Million by 2030, growing at a CAGR of 4.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Ophthalmic Viscosurgical Devices market.

Global Ophthalmic Viscosurgical Devices Market - Key Trends & Drivers Summarized

Why Are Viscosurgical Devices Indispensable in Modern Ocular Surgery?

Ophthalmic Viscosurgical Devices (OVDs) have established themselves as a cornerstone in ocular surgeries, particularly cataract procedures, by offering critical intraoperative support. These gel-like substances, typically composed of sodium hyaluronate or other viscoelastic compounds, are essential in maintaining anterior chamber stability, protecting intraocular tissues, and facilitating intraocular lens (IOL) implantation. With cataract surgery being one of the most frequently performed procedures worldwide, the demand for reliable and high-performing OVDs continues to grow in parallel. Their role is even more vital in complex surgeries such as glaucoma filtering procedures, corneal transplants, and vitreoretinal interventions, where tissue protection and space maintenance are critical. As surgical techniques evolve toward micro-incisional and femtosecond laser-assisted procedures, the reliance on high-purity, phase-specific OVDs is increasing. This trend is reinforced by the rising geriatric population globally, which presents a larger pool of patients requiring age-related eye care interventions. Moreover, the consistent emphasis on post-operative outcomes and patient safety is pushing surgeons to adopt advanced OVDs that reduce endothelial damage and inflammation. Thus, these devices are not only essential from a surgical standpoint but are also becoming increasingly integrated into protocols focused on improving visual outcomes and recovery profiles.

How Is Product Innovation Elevating the Performance of OVDs?

Innovation in ophthalmic viscosurgical devices is reshaping surgical precision, safety, and efficiency. One of the most significant advancements is the development of dual-function OVDs - also known as dispersive-cohesive combinations - which offer the benefits of both space maintenance and tissue protection in a single application. These formulations simplify the surgical process and reduce the need for multiple product administrations. Manufacturers are also refining the molecular structure of viscoelastics to improve flow dynamics, increase transparency, and enhance retention within the anterior chamber. These improvements allow for better manipulation of ocular structures during phacoemulsification and IOL placement, particularly in complex cases such as small pupil or floppy iris syndrome. Additionally, pre-filled syringes and ergonomic delivery systems are being introduced to improve handling and minimize waste during procedures. Advances in cross-linked hyaluronic acid formulations are contributing to prolonged retention and better viscoelastic behavior under stress, aligning with the needs of modern, high-speed surgical techniques. Biocompatibility remains a major focus area, with innovations aiming to further reduce the risk of inflammation, IOP spikes, and post-op complications. Furthermore, research is ongoing into biodegradable and drug-eluting OVDs that could provide both mechanical and pharmacological benefits intraoperatively. These technological strides are not only boosting surgical outcomes but are also creating differentiation in a competitive market landscape.

What End-Use and Geographic Trends Are Defining Demand Patterns?

Demand for ophthalmic viscosurgical devices is being strongly influenced by both end-user preferences and regional healthcare developments. In high-income countries, where surgical infrastructure is advanced and patient expectations are high, ophthalmic surgeons increasingly prefer premium OVDs that offer enhanced performance and safety. The presence of well-established ophthalmology centers and high surgical throughput in countries like the U.S., Germany, and Japan ensures steady consumption of high-grade, branded OVDs. In contrast, emerging markets such as India, Brazil, and parts of Southeast Asia are witnessing rapid adoption driven by rising cataract surgery volumes, improved healthcare access, and government-backed blindness prevention initiatives. In these regions, cost-effective yet reliable OVDs are in demand to support high-volume eye care programs and mobile surgical camps. The increasing number of ambulatory surgical centers and standalone eye clinics is also expanding the buyer base for single-use, pre-sterilized OVDs that enable fast turnover and reduce the risk of contamination. Academic institutions and surgical training centers further contribute to demand as they incorporate OVD use into standardized surgical education protocols. Additionally, the rise of private equity-backed ophthalmology chains and franchised vision care networks is leading to centralized procurement and standardization of OVD brands, increasing market visibility for leading manufacturers. These trends underscore a clear shift toward more strategic and volume-driven purchasing behavior across different market tiers.

What Key Forces Are Fueling Growth in the Ophthalmic Viscosurgical Devices Market?

The growth in the ophthalmic viscosurgical devices market is driven by several factors related to technological refinement, surgical volume expansion, and shifts in clinical practice standards. One of the primary growth drivers is the global increase in cataract surgeries, supported by rising life expectancy and growing awareness of early vision restoration options. The transition toward minimally invasive and laser-assisted surgical techniques is increasing demand for OVDs that offer enhanced retention, clarity, and chamber stability under rapid intraoperative conditions. End-user demand for single-use, sterile, and pre-filled OVD formats is also growing, especially in ambulatory and high-throughput surgical centers. Continued product innovation, including dual-phase and viscoadaptive OVDs, is expanding clinical utility across a broader range of surgical scenarios, from standard lens implantation to advanced anterior and posterior segment procedures. In emerging markets, the expansion of vision care access through public health programs, non-governmental initiatives, and mobile surgical units is driving significant volumes of OVD consumption. Additionally, strategic collaborations between ophthalmic equipment manufacturers and pharmaceutical companies are enhancing product bundling and integrated surgical offerings. The growing penetration of training programs and simulation-based education in ophthalmology is increasing practitioner familiarity and confidence with advanced OVD usage. These combined factors are positioning ophthalmic viscosurgical devices as a critical and growing component within the broader landscape of global eye care.

Report Scope

The report analyzes the Ophthalmic Viscosurgical Devices market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Type (Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices, Viscoadaptive Ophthalmic Viscosurgical Devices); Source (Biological Source, Animal Source, Semi-Synthetic Source); Application (Cataract Surgery Application, Corneal Grafting Application, Glaucoma Surgery Application, Vitreoretinal Grafting Application)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Dispersive Ophthalmic Viscosurgical Devices segment, which is expected to reach US$293.8 Million by 2030 with a CAGR of a 3.6%. The Cohesive Ophthalmic Viscosurgical Devices segment is also set to grow at 6.0% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $117.1 Million in 2024, and China, forecasted to grow at an impressive 7.2% CAGR to reach $109.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Ophthalmic Viscosurgical Devices Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Ophthalmic Viscosurgical Devices Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Ophthalmic Viscosurgical Devices Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Advin Health Care, Alcon Inc., Altacor Limited, Amring Pharmaceuticals Inc., Bausch & Lomb Incorporated and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 39 Featured):

• Advin Health Care
• Alcon Inc.
• Altacor Limited
• Amring Pharmaceuticals Inc.
• Bausch & Lomb Incorporated
• Beaver-Visitec International Inc.
• Bloomage Biotechnology Corporation Limited
• Bohus Biotech AB
• Carl Zeiss Meditec AG
• CIMA Technology Inc.
• Eyebright Medical Technology Co., Ltd.
• Eyekon Medical Inc.
• Haohai Biological Technology
• Johnson & Johnson Surgical Vision, Inc.
• Maxigen Biotech Inc.
• Ophtechnics Unlimited
• Rayner Intraocular Lenses Limited
• RUMEX International Co.
• Santen Pharmaceutical Co., Ltd.
• Truviz Ophthalmic

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry